
J&J Proposes $5.5 Billion Settlement to End US Talc Cancer Litigation
Johnson & Johnson has proposed a $5.5 billion settlement to resolve approximately 69,000 US lawsuits alleging its discontinued talc-based baby powder caused ovarian cancer. The deal, which requires acceptance by 95% of claimants, follows a recent court ruling that plaintiffs failed to prove specific causation. While J&J denies the product causes cancer, it has already halted global sales of talc-based powder. A separate, massive UK case involving over 7,000 claimants remains pending and is not covered by this agreement.

